What the business is, and whether it's a good one at a fair price.
Manufactures specialty cellulose- and starch-based excipients including CCS, SSG and Calcium CMC, which it sells to repeat customers and exports to more than 15 countries. In FY26, revenue from operations grew 30.6% to ₹137.26 crore, with profit after tax of ₹1,255.22 lakhs, up 18.8% from the prior year. The company operates an existing manufacturing unit at Vatva and is building a new 6,012 MTPA greenfield plant at Indrad, Mahesana under a ₹45 crore turnkey contract with J&H Pharma Consultants, with commercial production originally targeted for March 2026. Raw materials account for 74.1% of revenue, with employees at 4.8% and other operating expenses at 7.9%, leaving ROCE of 16.48% on total assets of ₹142.28 crore. The company listed on BSE in July 2025, raising ₹58.80 crore to part-fund the new plant, of which ₹22.55 crore had been deployed by March 2026 and ₹36.24 crore remained parked in Axis Bank fixed deposits. Related party dealings include purchases from Av Celllose Products and Patel Industries, and sales to Patelchem North America Inc.
Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from PATEL CHEM SPECIALITIES LIMITE's filed financials and exchange disclosures
PATEL CHEM SPECIALITIES LIMITE is a Chemicals & Petrochemicals company listed on BSE.
Effectively yes. It holds ₹0 Cr more cash than debt.
On trailing P/E, PATEL CHEM SPECIALITIES LIMITE ranks 30 of 103 in Specialty Chemicals — cheaper than 72% of them, against an industry median of 23.4×. This is a position, not a valuation judgement.
On a typical session PATEL CHEM SPECIALITIES LIMITE moves 1.70% — that is the median absolute close-to-close move across its last 267 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by PATEL CHEM SPECIALITIES LIMITE appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
